Discovery and structure-activity relationship study of nicotinamide derivatives as DNA demethylase ALKBH2 inhibitors

Ke Xu1, Feng Li2, Liang Xiong2

  • 1Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, 610041, China.

Insights

Researchers developed AH2-14c, the first potent and selective inhibitor targeting AlkB homolog 2 (ALKBH2) DNA demethylase. This compound shows promise for glioblastoma treatment and further research into ALKBH2

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • AlkB homolog 2 (ALKBH2) is an Fe(II) and 2-oxoglutarate (2OG)-dependent DNA demethylase.
  • ALKBH2 is highly expressed in cancers like glioblastoma (GBM), influencing disease progression.
  • There is a lack of potent and selective ALKBH2 inhibitors for therapeutic or research use.

Purpose of the Study:

  • To discover and characterize novel potent and selective inhibitors of ALKBH2.
  • To evaluate the potential of these inhibitors as therapeutic agents for glioblastoma.
  • To explore the mechanism of action of ALKBH2 inhibition in cancer cells.

Main Methods:

  • Synthesis and screening of small molecule inhibitors.
  • Fluorescence polarization (FP) assay to determine IC50 values and selectivity.
  • Cellular assays to assess anti-viability, anti-proliferation, and anti-migration effects in GBM U87 cells.

Main Results:

  • AH2-15c identified as a potent ALKBH2 inhibitor (IC50 = 0.031 μM) with >200-fold selectivity.
  • AH2-14c, a cell-permeable derivative, demonstrated superior efficacy in increasing DNA 3meC modifications in GBM U87 cells.
  • AH2-14c exhibited significant anti-viability, anti-proliferation, and anti-migration activities in U87 cells.

Conclusions:

  • AH2-14c is the first potent and selective ALKBH2 inhibitor with demonstrated cellular activity.
  • This inhibitor holds potential as a foundation for developing new glioblastoma therapies.
  • Further studies can utilize AH2-14c to investigate ALKBH2's role in cancer biology.

Related Concept Videos

Nucleic Acid Structure01:25

Nucleic Acid Structure

The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms  a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
5.9K
The DNA Helix01:07

The DNA Helix

Deoxyribonucleic acid, or DNA, is the genetic material responsible for passing traits from generation to generation in all organisms and most viruses. DNA is composed of two strands of nucleotides that wind around each other to form a spring-like structure called a double helix. However, the double helix is not perfectly symmetrical. Instead, there are regularly occurring grooves in the structure. The major groove occurs where the sugar-phosphate backbones are relatively far apart. This space...
19.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
595
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
872
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
7